Literature DB >> 27554302

Physician's knowledge, attitudes, and practices regarding seasonal influenza, pandemic influenza, and highly pathogenic avian influenza A (H5N1) virus infections of humans in Indonesia.

Amalya Mangiri1, A Danielle Iuliano2, Yunita Wahyuningrum3, Catharina Y Praptiningsih1, Kathryn E Lafond2, Aaron D Storms2,4, Gina Samaan1, Iwan Ariawan5, Nugroho Soeharno5, Jennifer M Kreslake3, J Douglas Storey3, Timothy M Uyeki2.   

Abstract

Indonesia has reported highest number of fatal human cases of highly pathogenic avian influenza (HPAI) A (H5N1) virus infection worldwide since 2005. There are limited data available on seasonal and pandemic influenza in Indonesia. During 2012, we conducted a survey of clinicians in two districts in western Java, Indonesia, to assess knowledge, attitudes, and practices (KAP) of clinical diagnosis, testing, and treatment of patients with seasonal influenza, pandemic influenza, or HPAI H5N1 virus infections. Overall, a very low percentage of physician participants reported ever diagnosing hospitalized patients with seasonal, pandemic, or HPAI H5N1 influenza. Use of influenza testing was low in outpatients and hospitalized patients, and use of antiviral treatment was very low for clinically diagnosed influenza patients. Further research is needed to explore health system barriers for influenza diagnostic testing and availability of antivirals for treatment of influenza in Indonesia.
© 2016 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27554302      PMCID: PMC5155649          DOI: 10.1111/irv.12428

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


Background

Indonesia is considered an endemic country for highly pathogenic avian influenza (HPAI) A (H5N1) virus among poultry and reported the highest number of fatal human cases of HPAI H5N1 virus infection worldwide (199 cases and 84% mortality) during 2005 to 2015.1, 2 Most human cases of HPAI H5N1 in Indonesia have occurred in the western part of the main island of Java. The majority of HPAI H5N1 human cases have been associated with poultry exposure such as direct or close contact with sick or dead poultry or visiting a live poultry market, although limited, non‐sustained human‐to‐human HPAI H5N1 virus transmission has likely occurred.1, 3, 4, 5, 6, 7, 8 Mortality from HPAI H5N1 virus infection in Indonesia has been associated with late presentation to health care and hospitalization, delayed clinical diagnosis of HPAI H5N1, and late initiation of antiviral treatment.5, 9, 10, 11 In addition to sporadic human infections with HPAI H5N1 virus in Indonesia, seasonal influenza A and B viruses circulate among people. Limited surveillance data suggest that seasonal influenza viruses circulate year‐round in Indonesia, with increased activity during November to March, the rainy season months.12, 13, 14, 15 However, data on seasonal influenza disease burden in Indonesia are limited. In addition, there are no published data on the impact of the 2009 H1N1 pandemic in Indonesia. To assess clinicians’ familiarity with clinical management of influenza patients in Indonesia, we conducted a survey of outpatient and hospital‐based physicians in two districts in western Java: East Jakarta and Bogor. The objectives of the survey were to determine the knowledge, attitudes, and practices (KAP) of physicians about clinical diagnosis, testing, and treatment of patients with seasonal influenza, pandemic influenza, or HPAI H5N1 virus infections. In both of these districts, human cases of HPAI H5N1 virus infection had been identified as recently as 2009 prior to implementation of the survey. In this report, we summarize the findings of the KAP survey.

Materials and Methods

We conducted a cross‐sectional survey of practicing clinicians in western Java, Indonesia. The study population was comprised of outpatient‐ and inpatient‐based physicians providing medical care for adult and/or pediatric patients at government or private sector health facilities in Bogor (peri‐urban and rural communities) and East Jakarta (primarily urban) districts. We utilized a list of all registered physicians from the District Health Offices in the two districts and randomly sampled general primary care clinicians and subspecialists from the list for recruitment. A standardized data collection instrument was developed with 119 questions about influenza KAP. The instrument was piloted with clinicians in Depok, West Java, to confirm the wording, flow, and time spent for each respondent. Study personnel were trained to use the instrument. Following verbal informed consent from clinician participants, face‐to‐face interviews were conducted in Bahasa Indonesia, the Indonesian language, during March to June 2012. We collected demographic information and data on participants’ clinical practice setting, knowledge of influenza signs, symptoms, and complications, outpatient and inpatient influenza diagnosis, testing, treatment, and preventive measures for seasonal influenza, pandemic influenza, and HPAI H5N1, including the H5N1 suspect case definition used in Indonesia. The suspect case definition for HPAI H5N1 in Indonesia includes acute lower respiratory tract illness with fever and recent exposure to poultry or suspected human cases within 7 days of illness onset and is based upon the World Health Organization (WHO) suspect H5N1 case definition.16, 17 Clinicians were asked about a series of clinical signs and symptoms that are commonly associated with influenza to see whether they thought a particular sign or symptom was related to seasonal influenza, pandemic influenza during the 2009 H1N1 pandemic (2009–2010), or HPAI H5N1 virus infection in hospitalized patients or outpatients. Distinguishing between seasonal and pandemic influenza on clinical grounds may be impossible. However, because of the lack of published data on the 2009 H1N1 pandemic in Indonesia, we were interested whether clinicians were aware of the influenza pandemic and if they had ever diagnosed a patient with 2009 H1N1. Survey responses were entered into a database using epidata version 3.1 (EpiData Association, Odense, Denmark) with double entry to confirm responses, and data were analyzed using IBM Statistical Product and Service Solutions (spss) version 20 (IBM Co. Somers, New York). Descriptive statistics were calculated to analyze the results using spss. Human subjects review for the study was conducted and approved by the Ethics Committee of the Faculty of Public Health, Universitas Indonesia, with reliance approval by the U.S. Centers for Disease Control and Prevention Institutional Review Board.

Results

Demographic characteristics

Of 1 725 registered physicians, 1 130 (66%) physicians were approached in the two districts and of those 554 (49%) were enrolled in the survey (Table 1). The 595 physicians who were not approached to participate did not have a valid address for contact or were no longer practicing physicians. Of the 554 physicians enrolled, the median age was 41 years (interquartile range (IQR): 32–50 years), 42% were male, 43% were from East Jakarta; 88% were general practitioners and 12% were specialists including pediatricians (3%), internists (3%), and obstetricians/gynecologists (2%). Overall, 71% of physicians reported providing outpatient care only, 2% provided inpatient care only, and 27% provided both outpatient and inpatient care.
Table 1

Demographic characteristics of surveyed physicians, two districts in Indonesia, March–June 2012

Physician characteristicsPhysicians (N=554)n (%)
Age (years)
Median (IQR)41 (32–50)
Gender
Female323 (58)
Physician specialty
General physician489 (88)
Subspecialty65 (12)
Obstetrician/Gynecologist13 (2)
Pediatricians16 (3)
Internal medicine14 (3)
Pulmonologist8 (1)
Cardiologist2 (0.4)
Neurologist6 (1)
Ear, nose, and throat (ENT)specialist6 (1)
Type of care provided
Outpatient392 (71)
Inpatient (hospitalized)13 (2)
Outpatient & inpatient149 (27)
Demographic characteristics of surveyed physicians, two districts in Indonesia, March–June 2012

Reported knowledge about clinical features of influenza

Clinical signs and symptoms associated with seasonal influenza in outpatients reported by physicians were generally similar for the two districts. Fever (96%), cough (85%), runny nose (75%), nasal congestion (64%), and sneezing (58%) were reported by physicians to be associated with seasonal influenza in outpatients (Table 2). Physicians reported that shortness of breath (24%) was a symptom for hospitalized seasonal influenza patients more frequently than in outpatients (7%).
Table 2

Physician reported knowledge of signs and symptoms of seasonal influenza, pandemic influenza A(H1N1)pdm09, and HPAI H5N1 virus infections

Clinical signs and symptomsa Seasonal influenzan (%)A(H1N1)pdm09n (%)HPAI H5N1n (%)
Outpatients
Fever533 (96)478 (86)503 (91)
Cough473 (85)366 (66)407 (74)
Runny nose414 (75)274 (50)303 (55)
Nasal congestion356 (64)235 (42)253 (46)
Sneezing322 (58)201 (36)210 (38)
Muscle ache280 (51)291 (53)299 (54)
Sore throat268 (48)223 (40)235 (42)
Shortness of breath40 (7)108 (20)216 (39)
Hospitalized patients
Fever525 (95)468 (85)499 (90)
Cough445 (80)354 (64)400 (72)
Runny nose374 (68)265 (48)281 (51)
Nasal congestion322 (58)231 (42)244 (44)
Sneezing280 (51)188 (34)202 (37)
Muscle ache270 (49)288 (52)296 (53)
Sore throat268 (48)221 (40)238 (43)
Shortness of breath131 (24)185 (33)301 (54)

All signs and symptoms can occur with seasonal influenza, pandemic influenza, and highly pathogenic avian influenza (HPAI) A(H5N1); higher percentage indicates more knowledgeable responses.

Physician reported knowledge of signs and symptoms of seasonal influenza, pandemic influenza A(H1N1)pdm09, and HPAI H5N1 virus infections All signs and symptoms can occur with seasonal influenza, pandemic influenza, and highly pathogenic avian influenza (HPAI) A(H5N1); higher percentage indicates more knowledgeable responses. For pandemic influenza [influenza A(H1N1)pdm09], fever, cough, muscle ache, runny nose, and nasal congestion were less frequently reported by physicians as being signs and symptoms in both outpatients and hospitalized patients (Table 2). In addition, physicians reported that fever (91%), cough (74%), runny nose (55%), muscle aches (54%), and nasal congestion (46%) were signs or symptoms for suspected HPAI H5N1 in outpatients. For suspected HPAI H5N1 hospitalized patients, physicians more frequently reported that shortness of breath (54%) was a sign of suspected HPAI H5N1 in hospitalized patients compared to outpatients (39%) (Table 2).

Knowledge of seasonal influenza high‐risk groups

Physicians correctly identified children aged <5 years old (92%), immunosuppressed persons (64%), and elderly (64%) as high‐risk groups for seasonal influenza‐associated complications. However, 41% correctly identified persons with chronic lung disease and pregnant women, and few participants (17%) identified persons with heart disease as high‐risk groups for influenza‐associated complications. 76% of physicians incorrectly identified children aged >5 years as a high‐risk group for influenza complications. Overall, the findings were similar for participating physicians in the two districts (data not shown).

Knowledge of HPAI H5N1 suspect case definition and risk factors

Among all clinicians in the two districts, 98% reported having heard of the HPAI H5N1 suspect case definition in Indonesia. However, when asked about what potential exposures physicians would ask of suspected HPAI H5N1 patients, many physicians reported that they would not ask about key risk factors for HPAI H5N1 virus infection. While 59% of physicians reported that they would ask whether a patient had handled dead chickens in the 7 days before illness onset, only 13% reported that they would ask about contact with chickens that died suddenly, and only 9% reported that they would ask about visiting a market where live poultry were slaughtered in the 7 days prior to illness onset to assess potential HPAI H5N1 virus exposures. Twenty‐two percent of physicians reported that they would inquire about slaughtering chickens by patients in the prior 7 days to determine HPAI H5N1 virus exposure. In contrast, to assess exposure to HPAI H5N1 virus, more than 50% of physicians reported that they would ask about uncommon risk factors for HPAI H5N1 virus infection, such as exposures to wild birds or wild bird feces near the home in the past 7 days (53%) or whether the suspected case had provided care to a confirmed HPAI H5N1 case patient (54%).

Practices related to influenza diagnosis, testing, and treatment

Among outpatient‐based physicians, over 90% reported ever making a clinical diagnosis of seasonal influenza (not laboratory‐confirmed), but only 2% reported having diagnosed pandemic influenza, and 4% reported having diagnosed a case of suspected HPAI H5N1 (Table 3). Among physicians providing care for hospitalized patients, 28% reported ever making a clinical diagnosis of seasonal influenza, while only 0.2% reported having diagnosed pandemic influenza, and 1% had diagnosed a suspected case of HPAI H5N1.
Table 3

Physician reported practices for the diagnosis, treatment, and testing of seasonal influenza, influenza A(H1N1)pdm09, or HPAI H5N1 virus infections in outpatients and hospitalized patients (N=554)

Suspected influenza diseaseInfluenza clinically diagnosedInfluenza treatment prescribedInfluenza testing ordered
Over the counter fever or pain reducing medicinea AntibioticAntiviral
n (%)n (%)n (%)n (%)n (%)
Physicians caring for Outpatients (n=541)Seasonal Influenza512 (95)512 (100)235 (46)16 (3)12 (2)
A(H1N1)pdm099 (2)5 (56)4 (44)2 (22)4 (44)
HPAI H5N121 (4)6 (29)6 (29)
Physicians caring for Hospitalized patients (n=162)Seasonal Influenza46 (28)39 (85)30 (65)2 (4)8 (17)
A(H1N1)pdm091 (0.1)1 (100)1 (100)1 (100)1 (100)
HPAI H5N17 (4)4 (57)4 (57)

Such as paracetamol.

Physician reported practices for the diagnosis, treatment, and testing of seasonal influenza, influenza A(H1N1)pdm09, or HPAI H5N1 virus infections in outpatients and hospitalized patients (N=554) Such as paracetamol. Among physicians who had clinically diagnosed seasonal influenza in the outpatient setting, only 2% had ordered influenza testing, whereas among those who had made such a diagnosis in the inpatient setting, 17% had ordered influenza testing. Among all physicians who indicated that they ordered influenza testing, 57% reported ordering testing for hospitalized patients who were suspected HPAI H5N1 cases compared to 29% for outpatients (Table 3). Among physicians providing care for outpatients, the most common reported reason that testing was not ordered for seasonal influenza in outpatients was because testing was thought to be unnecessary, too expensive, or was unavailable. Medicines for relief of symptoms and antibiotics were the most frequently reported treatment prescribed for influenza patients (Table 3). Very few physicians reported prescribing antiviral treatment for seasonal influenza in outpatients (3%) or hospitalized patients (4%).

Knowledge and practice related to Influenza non‐pharmaceutical preventive measures

When asked about ways to prevent influenza, more than half of physicians reported that they recommended that outpatients they diagnosed with suspected seasonal influenza should use a face mask (57%), cover their nose and mouth when sneezing and coughing (44%), and wash hands frequently (38%), but only 13% reported that they would tell the patient to avoid close contact with non‐ill persons. Forty‐eight percent of physicians reported that they recommended that outpatients diagnosed with suspected HPAI H5N1 should cover their nose and mouth when coughing and sneezing, and wear a face mask, and 57% recommended avoiding close contact with other persons. For hospitalized patients diagnosed with seasonal influenza, physicians reported recommending that the patient should use a face mask (76%), cover the nose or mouth when sneezing or coughing (67%), and wash their hands frequently (46%) to reduce influenza virus transmission to others (Table 4). However, only 26% physicians reported recommending that the patient should limit interactions and avoid close contact with healthy persons to prevent spread of influenza. Only 6 (1%) physicians reported diagnosing a hospitalized patient with suspected HPAI H5N1, and of those, only 3 (50%) recommended that the patient should wear a face mask and avoid close contact with healthy persons to prevent further transmission (Table 4).
Table 4

Physician practices for recommending non‐pharmaceutical preventive measures for patients diagnosed with suspected seasonal influenza, pandemic influenza, and HPAI H5N1 in outpatients and hospitalized patients

Recommended preventive measuresSeasonal InfluenzaA(H1N1)pdm09HPAI H5N1
Outpatients(N=512) n (%)Hospitalized patients (N=46) n (%)Outpatients (N=9) n (%)Hospitalized patients (N=1) n (%)Outpatients (N=21) n (%)Hospitalized patients (N=6) n (%)
Frequent hand washing by patients208 (38)21 (46)2 (22)1 (100)3 (14)3 (50)
Patient should cover nose and mouth when coughing and sneezing245 (44)31 (67)5 (56)1 (100)10 (48)3 (50)
Patient should use face mask313 (57)35 (76)6 (67)1 (100)11 (52)3 (50)
Patient should limit interaction with persons who are not sick144 (26)12 (26)6 (67)1 (100)6 (29)1 (17)
Patient should avoid close contact with healthy persons72 (13)10 (22)0 (0)1 (100)12 (57)3 (50)
Physician practices for recommending non‐pharmaceutical preventive measures for patients diagnosed with suspected seasonal influenza, pandemic influenza, and HPAI H5N1 in outpatients and hospitalized patients Of the 28 physicians who reported making a diagnosis of suspected HPAI H5N1 (outpatients: n=21, hospitalized patients n=7), 83% reported wearing a surgical mask to help prevent exposure to a patient with suspected HPAI H5N1 virus infection. However, only 50% reported placing the patient with suspected HPAI H5N1 virus infection in an isolation room.

Practice related to influenza vaccination

Only 11% of all physicians reported they had received influenza vaccination in the previous 12 months. Of those that reported receiving influenza vaccination, 82% reported receiving seasonal trivalent influenza vaccine, and 15% could not recall what kind of influenza vaccine they received. Reasons reported by physicians for not receiving influenza vaccine included that they believed being vaccinated was not important (47%), they were not interested in vaccination (24%), vaccine was unavailable (19%), vaccine was too expensive (9%), and vaccine was not effective (3%).

Discussion

In this descriptive survey of physicians providing care for outpatients and hospitalized patients in two districts located in western Java, Indonesia, most physicians reported that they were generally familiar with the signs and symptoms associated with influenza. Nearly all physicians reported making a clinical diagnosis of seasonal influenza in outpatients, but most had not diagnosed influenza in hospitalized patients. Very few physicians reported ever diagnosing a patient with pandemic influenza or with suspected HPAI H5N1 in either outpatients or hospitalized patients. A recent one‐year surveillance study reported that 15.5% of hospitalized patients with severe acute respiratory infection (SARI) tested positive for influenza viruses, including 36% during weeks of peak influenza activity in East Jakarta District, Jakarta, Indonesia.15 Together with our findings, this suggests that Indonesian clinicians need to be educated further about the potential for influenza to cause severe illness resulting in hospitalization. Additionally, physicians should be educated on the value of surveillance data to better understand when seasonal influenza viruses are circulating and on the burden of seasonal influenza in Indonesia, such as the results of ongoing enhanced influenza surveillance among SARI patients.15 Almost all physicians reported that they had heard of the suspect HPAI H5N1 case definition in Indonesia and were familiar with some risk factors, but most physicians seemed unaware of certain established risk factors for human infection with HPAI H5N1 virus, such as contact with poultry that died suddenly or visiting a live poultry market where poultry are slaughtered.18 In contrast, more than half of physicians thought that very uncommon risk factors, such as providing care for a suspected HPAI H5N1 patient and recent exposure to wild birds or wild bird feces near the home, were exposures to ask about to patients with suspected HPAI H5N1 virus infection. Despite practicing medicine in districts where human cases of HPAI H5N1 virus infection have been identified, these findings indicate that much more education of physicians is needed about risk factors for HPAI H5N1 virus infection. Educational training of physicians, such as that conducted in Vietnam, and continuing medical education modules, could improve clinician knowledge of HPAI H5N1 risk factors and clinical management of patients with suspected HPAI H5N1 virus infection in Indonesia.19 Furthermore, according to Ministry of Health policy, any suspected case of HPAI H5N1 virus infection should be referred as soon as possible to a designated H5N1 referral hospital for immediate antiviral treatment and H5‐specific testing.16 Most physicians who participated in the survey were aware that young children, elderly, and immunosuppressed persons are at increased risk for seasonal influenza complications, but a majority were not aware that pregnant women, and persons with chronic lung or cardiac disease comprise high‐risk groups for influenza complications.20 These findings indicate that education of Indonesian clinicians is needed about influenza complications and high‐risk groups, especially to facilitate prevention and prompt treatment of influenza. Most physicians reported never ordering influenza diagnostic testing and more frequently reported treating influenza patients with non‐specific medications for symptomatic relief and antibiotics. Very few physicians reported prescribing antiviral treatment for the patients. This could be due to unawareness of the clinical benefit of antiviral treatment, lack of availability of antiviral medications for influenza or because Indonesian Ministry of Health policy only recommends antiviral treatment for patients who are suspected or confirmed with HPAI H5N1 virus infection, and for healthcare workers who are providing care for HPAI H5N1 patients.16, 21 Of the very small number of physicians who reported diagnosing a patient with suspected HPAI H5N1 virus infection, most reported not prescribing antiviral treatment for outpatients and slightly more than half reported prescribing antivirals for hospitalized patients. Observational studies suggest that early antiviral treatment has greater clinical benefit such as mortality reduction compared to no treatment or late treatment for hospitalized influenza patients, including those with HPAI H5N1 virus infection.9, 10, 22, 23 Few respondents reported using recommended measures to prevent influenza transmission. Only a small number of physicians reported having received seasonal influenza vaccination in the previous year. This finding is not surprising since no national influenza vaccination program exists in Indonesia. Overall, physicians who made a diagnosis of influenza in a hospitalized patient reported recommending more preventive measures than in outpatients. Of the small number of physicians who reported diagnosing a patient with suspected HPAI H5N1 virus infection, only about half reported placing the patient in an isolation room. These findings suggest that Indonesian physicians might benefit from more education about how influenza viruses are transmitted and of measures to prevent and control influenza in healthcare workers and healthcare settings as recommended by the World Health Organization.24, 25 There were limitations to this KAP survey. The survey was conducted a few years after the 2009 H1N1 pandemic was declared over and clinicians may not have recalled making a diagnosis of pandemic influenza during 2009–2010. Laboratory testing for distinguishing seasonal influenza from 2009 H1N1 was not widely available and may have limited a diagnosis of 2009 H1N1 during the pandemic period of 2009–2010. Overall participation of eligible physicians from the two districts was low (49% of recruited physicians participated in the survey and 32% of 1750 registered physicians). Therefore, the findings may not be representative or generalizable to all physicians practicing in East Jakarta or Bogor districts, or in Indonesia.

Conclusions

Overall, a very low percentage of physician participants reported ever diagnosing seasonal influenza, pandemic influenza, or HPAI H5N1 in hospitalized patients. Use of influenza testing was low in outpatients and hospitalized patients, and use of antiviral treatment was very low for clinically diagnosed influenza patients. Further research is needed to explore health system barriers for influenza diagnostic testing and availability of antivirals for treatment of influenza in Indonesia.

Disclaimer

The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.
  19 in total

Review 1.  Managing seasonal influenza: oseltamivir treatment policy in indonesia?

Authors:  Herman Kosasih; Arie Bratasena; Krisna Pangesti; Kanti Laras; Gina Samaan
Journal:  Acta Med Indones       Date:  2014-01

2.  Vaccines against influenza WHO position paper – November 2012.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2012-11-23

3.  Three Indonesian clusters of H5N1 virus infection in 2005.

Authors:  I Nyoman Kandun; Hariadi Wibisono; Endang R Sedyaningsih; Widarso Hadisoedarsuno; Wilfried Purba; Hari Santoso; Chita Septiawati; Erna Tresnaningsih; Bambang Heriyanto; Djoko Yuwono; Syahrial Harun; Santoso Soeroso; Sardikin Giriputra; Patrick J Blair; Andrew Jeremijenko; Herman Kosasih; Shannon D Putnam; Gina Samaan; Marlinggom Silitonga; K H Chan; Leo L M Poon; Wilina Lim; Alexander Klimov; Stephen Lindstrom; Yi Guan; Ruben Donis; Jacqueline Katz; Nancy Cox; Malik Peiris; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

4.  Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series.

Authors:  I Nyoman Kandun; Erna Tresnaningsih; Wilfried H Purba; Vernon Lee; Gina Samaan; Syahrial Harun; Eka Soni; Chita Septiawati; Tetty Setiawati; Elvieda Sariwati; Toni Wandra
Journal:  Lancet       Date:  2008-08-14       Impact factor: 79.321

5.  Determinants of antiviral effectiveness in influenza virus A subtype H5N1.

Authors:  Paul K S Chan; Nelson Lee; Mukhtiar Zaman; Wiku Adisasmito; Richard Coker; Wanna Hanshaoworakul; Viktor Gasimov; Ahmet Faik Oner; Nazim Dogan; Owen Tsang; Bounlay Phommasack; Sok Touch; Ebun Bamgboye; Anna Swenson; Stephen Toovey; Nancy A Dreyer
Journal:  J Infect Dis       Date:  2012-08-20       Impact factor: 5.226

6.  Risk factors for human illness with avian influenza A (H5N1) virus infection in China.

Authors:  Lei Zhou; Qiaohong Liao; Libo Dong; Yang Huai; Tian Bai; Nijuan Xiang; Yuelong Shu; Wei Liu; Shiwen Wang; Pengzhe Qin; Min Wang; Xuesen Xing; Jun Lv; Ray Y Chen; Zijian Feng; Weizhong Yang; Timothy M Uyeki; Hongjie Yu
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

7.  Avian influenza H5N1 transmission in households, Indonesia.

Authors:  Tjandra Y Aditama; Gina Samaan; Rita Kusriastuti; Ondri Dwi Sampurno; Wilfried Purba; Hari Santoso; Arie Bratasena; Anas Maruf; Elvieda Sariwati; Vivi Setiawaty; Kathryn Glass; Kamalini Lokuge; Paul M Kelly; I Nyoman Kandun
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

8.  Impact of education and network for avian influenza H5N1 in human: knowledge, clinical practice, and motivation on medical providers in Vietnam.

Authors:  Toshie Manabe; Thi Phuong Thuy Pham; Koichiro Kudo; Thi Tuong Van Vu; Jin Takasaki; Dang Tuan Nguyen; Xuan Co Dao; Hung Minh Dang; Shinyu Izumi; Gia Binh Nguyen; Quy Chau Ngo; Thuy Hanh Tran
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

9.  Surveillance of influenza in Indonesia, 2003–2007.

Authors:  Herman Kosasih; Alexander Klimov; Xu Xiyan; Stephen Lindstrom; Frank Mahoney; Charmagne Beckett; Timothy H Burgess; Patrick J Blair; Timothy M Uyeki; Endang R Sedyaningsih
Journal:  Influenza Other Respir Viruses       Date:  2013-05       Impact factor: 4.380

10.  The East Jakarta Project: surveillance for highly pathogenic avian influenza A(H5N1) and seasonal influenza viruses in patients seeking care for respiratory disease, Jakarta, Indonesia, October 2011-September 2012.

Authors:  A D Storms; R Kusriastuti; S Misriyah; C Y Praptiningsih; M Amalya; K E Lafond; G Samaan; R Triada; A D Iuliano; M Ester; R Sidjabat; K Chittenden; R Vogel; M A Widdowson; F Mahoney; T M Uyeki
Journal:  Epidemiol Infect       Date:  2015-04-27       Impact factor: 4.434

View more
  2 in total

1.  Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections.

Authors:  Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

2.  The Intersection of Care Seeking and Clinical Capacity for Patients With Highly Pathogenic Avian Influenza A (H5N1) Virus in Indonesia: Knowledge and Treatment Practices of the Public and Physicians.

Authors:  Jennifer M Kreslake; Yunita Wahyuningrum; Angela D Iuliano; Aaron D Storms; Kathryn E Lafond; Amalya Mangiri; Catharina Y Praptiningsih; Basil Safi; Timothy M Uyeki; J Douglas Storey
Journal:  Disaster Med Public Health Prep       Date:  2016-06-14       Impact factor: 1.385

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.